BR112018010616A2 - compostos inibidores seletivos de mmp-12 - Google Patents

compostos inibidores seletivos de mmp-12

Info

Publication number
BR112018010616A2
BR112018010616A2 BR112018010616A BR112018010616A BR112018010616A2 BR 112018010616 A2 BR112018010616 A2 BR 112018010616A2 BR 112018010616 A BR112018010616 A BR 112018010616A BR 112018010616 A BR112018010616 A BR 112018010616A BR 112018010616 A2 BR112018010616 A2 BR 112018010616A2
Authority
BR
Brazil
Prior art keywords
mmp
selective inhibitor
inhibitor compounds
compounds
cosmetic
Prior art date
Application number
BR112018010616A
Other languages
English (en)
Other versions
BR112018010616B1 (pt
Inventor
Jackson Eileen
Ursula Wandeler Eliane
Herbert Vollhardt Jürgen
Wikstroem Peter
Schuetz Rolf
Boudon Stéphanie
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BR112018010616A2 publication Critical patent/BR112018010616A2/pt
Publication of BR112018010616B1 publication Critical patent/BR112018010616B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • C07F9/655354—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/16—Halogenated acetic acids
    • C07C53/18—Halogenated acetic acids containing fluorine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/306—Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Abstract

esta invenção se refere a compostos que são inibidores seletivos de metaloprotease de matriz-12 (mmp-12), a composições cosméticas e farmacêuticas que os contêm, e ao seu uso na prevenção e/ou tratamento de doenças associadas a mmp-12.
BR112018010616-0A 2015-11-30 2016-11-23 Compostos inibidores seletivos de mmp-12 e composição cosmética compreendendo o referido composto BR112018010616B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15197009 2015-11-30
EPEP15197009.2 2015-11-30
PCT/EP2016/078511 WO2017093093A1 (en) 2015-11-30 2016-11-23 Phosphinic peptide derivatives for use as mmp-12 inhibitors

Publications (2)

Publication Number Publication Date
BR112018010616A2 true BR112018010616A2 (pt) 2018-11-13
BR112018010616B1 BR112018010616B1 (pt) 2022-01-04

Family

ID=54754517

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018010616-0A BR112018010616B1 (pt) 2015-11-30 2016-11-23 Compostos inibidores seletivos de mmp-12 e composição cosmética compreendendo o referido composto

Country Status (6)

Country Link
US (1) US10179797B2 (pt)
JP (1) JP6938817B2 (pt)
KR (1) KR20180084062A (pt)
CN (1) CN108290912B (pt)
BR (1) BR112018010616B1 (pt)
WO (1) WO2017093093A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3881821A1 (en) 2020-03-19 2021-09-22 DSM IP Assets B.V. Phosphinic peptide derivatives for use as mmp-3 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2755135B1 (fr) * 1996-10-25 2002-12-27 Inst Nat Sante Rech Med Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent
ATE492532T1 (de) * 2004-03-26 2011-01-15 Dsm Ip Assets Bv Aminosäure- und peptid-konjugate von arylalkylsäuren zur verwendung in der kosmetik
EP1727516B1 (en) * 2004-03-26 2014-05-14 DSM IP Assets B.V. Composition comprising an hdac inhibitor in combination with a retinoid

Also Published As

Publication number Publication date
WO2017093093A1 (en) 2017-06-08
US20180319829A1 (en) 2018-11-08
BR112018010616B1 (pt) 2022-01-04
JP2019501122A (ja) 2019-01-17
JP6938817B2 (ja) 2021-09-22
KR20180084062A (ko) 2018-07-24
CN108290912B (zh) 2021-02-05
CN108290912A (zh) 2018-07-17
US10179797B2 (en) 2019-01-15

Similar Documents

Publication Publication Date Title
DOP2017000109A (es) Derivados de feniltriazol sustituido con hidroxialquilo y sus usos
BR112017022604A2 (pt) composto, composição farmacêutica, uso de um composto e de uma combinação, e, combinação
CL2018000542A1 (es) Nuevos derivados de fenoximetilo.
CO2017001994A2 (es) Compuestos activos hacia bromodominios
BR112016020199A8 (pt) composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso
BR112016015449A8 (pt) compostos inibidores terapêuticos, composição farmacêutica os compreendendo e uso dos mesmos
BR112015029969A2 (pt) tratamento de câncer usando moduladores de isoformas quinase pi3
BR112017012342A2 (pt) compostos inibitórios de bcl-xl e conjugados de anticorpo-fármaco incluindo os mesmos
CL2015003442A1 (es) Derivados heterociclicos
BR112017018276A2 (pt) ?composição que compreende peptidase e biotensoativo e seu uso?
NI201600071A (es) Compuestos de inhibidor de autotaxina
BR112016018555A8 (pt) Ciclopropilaminas como inibidores de lsd1, seu uso, composição farmacêutica que os compreende e método de inibição de lsd1
BR112017004704A2 (pt) composto, composição farmacêutica, e, método para tratar uma doença ou distúrbio em um indivíduo
BR112017008840A2 (pt) intensificador de inibidores do homólogo 2 de zeste
BR112017003433A2 (pt) inibidores espirocíclicos de catepsina c
BR112017004153A2 (pt) métodos para tratamento de infecções por protozoários
BR112016028845A2 (pt) composto, composição farmacêutica e uso de um composto
BR112017002060A2 (pt) novo uso
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
BR112022008365A2 (pt) Inibidores de cd73
BR112017008496A2 (pt) compostos para uso em tratamento antelmíntico
BR112017018198A2 (pt) inibição da atividade de olig2
BR112017004580A2 (pt) composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento.
DOP2019000221A (es) Derivados de pirazol como inhibidores de bromodominio
BR112017020053A2 (pt) novo composto heterocíclico, método para a preparação do mesmo e composição farmacêutica compreendendo o mesmo

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/11/2016, OBSERVADAS AS CONDICOES LEGAIS.